IART

24.58

0.16% 0.04

Handel nachbörslich: 24.58

Integra Lifesciences Holdings Corp (IART)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$24.54

Offen:

$24.59

24-Stunden-Volumen:

235.48K

Relative Volume:

0.25

Marktkapitalisierung:

$1.90B

Einnahmen:

$1.53B

Nettoeinkommen (Verlust:

$40.23M

KGV:

20.31

EPS:

1.21

Netto-Cashflow:

$60.93M

1W Leistung:

+4.24%

1M Leistung:

+26.05%

6M Leistung:

-16.96%

1J Leistung:

-37.22%

1-Tages-Spanne:

$24.39

$24.87

1-Wochen-Bereich:

$23.44

$24.87

52-Wochen-Spanne:

$16.80

$45.42

Integra Lifesciences Holdings Corp Stock (IART) Company Profile

Firmenname

Integra Lifesciences Holdings Corp

Sektor

Healthcare (1180)

Branche

Medical Devices (148)

Telefon

(609) 275-0500

Adresse

1100 CAMPUS ROAD, PRINCETON, NJ

Mitarbeiter

3,946

Twitter

@integra_life

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

IART's Discussions on Twitter

Vergleichen Sie IART mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IART Integra Lifesciences Holdings Corp	24.58	1.90B	1.53B	40.23M	60.93M	0.50
ABT Abbott Laboratories	118.77	206.00B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	392.15	149.49B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	90.66	133.62B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	86.54	110.97B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	71.35	42.08B	6.60B	4.16B	490.10M	6.93

Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-10-07	Hochstufung	BTIG Research	Sell → Neutral
2024-07-30	Herabstufung	BTIG Research	Neutral → Sell
2024-07-30	Herabstufung	Citigroup	Neutral → Sell
2024-05-07	Herabstufung	Oppenheimer	Outperform → Perform
2024-05-07	Herabstufung	Wells Fargo	Overweight → Equal Weight
2024-04-03	Hochstufung	Citigroup	Sell → Neutral
2023-12-05	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-11-14	Eingeleitet	CL King	Buy
2023-08-24	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2023-07-12	Hochstufung	Jefferies	Hold → Buy
2023-06-08	Herabstufung	Argus	Buy → Hold
2023-05-24	Herabstufung	JP Morgan	Neutral → Underweight
2023-05-23	Herabstufung	Citigroup	Neutral → Sell
2022-10-12	Eingeleitet	Jefferies	Hold
2022-07-25	Eingeleitet	Morgan Stanley	Equal-Weight
2022-04-13	Herabstufung	Truist	Buy → Hold
2021-12-17	Hochstufung	JP Morgan	Underweight → Neutral
2021-09-15	Herabstufung	BTIG Research	Buy → Neutral
2020-10-08	Herabstufung	JP Morgan	Neutral → Underweight
2020-05-27	Eingeleitet	Citigroup	Neutral
2020-04-03	Eingeleitet	SunTrust	Buy
2020-01-07	Herabstufung	Piper Jaffray	Overweight → Neutral
2020-01-07	Herabstufung	Piper Sandler	Overweight → Neutral
2019-01-03	Eingeleitet	SunTrust	Buy
2018-11-28	Eingeleitet	UBS	Neutral
2018-08-07	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-07-26	Hochstufung	BTIG Research	Neutral → Buy
2018-07-02	Herabstufung	Citigroup	Buy → Neutral
2018-01-05	Fortgesetzt	Cantor Fitzgerald	Neutral
2018-01-02	Herabstufung	BofA/Merrill	Buy → Neutral
2017-11-09	Bestätigt	RBC Capital Mkts	Sector Perform
2017-10-30	Herabstufung	Wells Fargo	Outperform → Market Perform
2017-10-27	Herabstufung	JP Morgan	Overweight → Neutral
2017-06-30	Eingeleitet	Cantor Fitzgerald	Overweight
2017-05-02	Bestätigt	RBC Capital Mkts	Sector Perform
2017-01-13	Bestätigt	RBC Capital Mkts	Sector Perform
2017-01-06	Hochstufung	JMP Securities	Mkt Perform → Mkt Outperform
2016-12-12	Eingeleitet	UBS	Buy

Alle ansehen

Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten

03:07 AM

Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Victory Capital Management Inc. - Defense World

03:07 AM

Nov 26, 2024

Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology - Benzinga

Nov 26, 2024

Nov 16, 2024

Regenerative Medicine Market to grow by USD 70.11 Billion (2024-2028), rising prevalence of chronic diseases to drive revenue, Report with AI-powered insightsTechnavio - The Malaysian Reserve

Nov 16, 2024

Nov 13, 2024

Integra Lifesciences (IART) Stock Dips Amid Financial Concerns - GuruFocus.com

Nov 13, 2024

Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research - Yahoo Finance

Nov 13, 2024

Fuller & Thaler Asset Management, Inc. Expands Stake in Integra Lifesciences Holdings Corp - GuruFocus.com

Nov 13, 2024

Capital Research Global Investors Reduces Stake in Integra Lifes - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by Analysts - MarketBeat

Nov 12, 2024

Nov 11, 2024

Integra LifeSciences : Serving Those Who Served - Marketscreener.com

Nov 11, 2024

Nov 09, 2024

Easterly Investment Partners LLC Has $1.12 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat

Nov 09, 2024

Nov 08, 2024

Leeward Investments LLC MA Has $6.83 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat

Nov 08, 2024

Nov 07, 2024

Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com

Nov 07, 2024

Olstein Capital Management L.P. Has $2.82 Million Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat

Nov 07, 2024

Wound Dressing Market: Size, Share, Trends, and Global Analysis - openPR

Nov 07, 2024

Nov 06, 2024

Integra LifeSciences price target raised to $22 from $16 at Citi - Yahoo Finance

Nov 06, 2024

Louisiana State Employees Retirement System Sells 2,200 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Nov 06, 2024

Nov 05, 2024

IART (Integra Lifesciences Holdings) PE Ratio without NRI : 8.77 (As of Nov. 05, 2024) - GuruFocus.com

Nov 05, 2024

Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure - MSN

Nov 05, 2024

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024

Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 05, 2024